RHEUMATOLOGY

Arthroplasty in patients with established rheumatoid arthritis (RA): Mitigating risks and optimizing outcomes

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Arthroplasty in patients with established rheumatoid arthritis (RA): Mitigating risks and optimizing outcomes

Abstract Patients with rheumatoid arthritis (RA) continue to undergo arthroplasty to relieve pain and restore lost function caused by joint damage, despite improvements in disease-modifying therapy. The widespread use of…

read more

De-intensifying treatment in established rheumatoid arthritis (RA): Why, how, when and in whom can DMARDs be tapered?

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on De-intensifying treatment in established rheumatoid arthritis (RA): Why, how, when and in whom can DMARDs be tapered?

Abstract As more patients with established rheumatoid arthritis (RA) achieve remission or low disease activity, strategies such as tapering and withdrawal of disease-modifying antirheumatic drugs (DMARDs) are being investigated. In…

read more

Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Cardiovascular disease in rheumatoid arthritis: Current perspectives on assessing and mitigating risk in clinical practice

Abstract That individuals with rheumatoid arthritis (RA) have, on average, higher rates of events related to atherosclerotic vascular disease is now well documented and accepted. However, optimal ways to identify…

read more

Pregnancy and rheumatoid arthritis

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Pregnancy and rheumatoid arthritis

Abstract Fertility is impaired in female patients with rheumatoid arthritis (RA), which is related to disease activity and the use of certain medication. During pregnancy, disease activity usually improves, but…

read more

Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars

Abstract There is increasing consensus that periodic monitoring of disease activity status in rheumatoid arthritis (RA) patients to achieve and maintain remission, or at least low disease activity (LDA), the…

read more

New therapeutic avenues in SLE

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on New therapeutic avenues in SLE

Abstract Although the use of corticosteroids and immunosuppressive agents such as cyclophosphamide and mycophenolate has led to reduced mortality in systemic lupus erythematosus (SLE), there is a need for development…

read more

Corrigendum to “Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis” [Best Pract Res Clin Rheumatol 29 (2) (2015) 290–305]

Nov 10, 2017 by in RHEUMATOLOGY Comments Off on Corrigendum to “Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis” [Best Pract Res Clin Rheumatol 29 (2) (2015) 290–305]

The authors regret that the following sentence on page 300 is inaccurate due to incorrect citations, “There is a suggestion, from the results presented in the primary studies, that the…

read more
Get Clinical Tree app for offline access